I remember having recommended Lincoln Pharma in these columns some time back. The stock has corrected because of the Tanzania issue. Management is trying hard to find the resolution to the FDA issue.
It is suggested that one can add few more numbers on this stock to bring down the existing buying price. Stock is otherwise carrying good fundamentals.